FK778

DRUG4 trials

Sponsors

Astellas Pharma Inc

Conditions

BK PolyomavirusGrafting, KidneyKidney DiseasesKidney TransplantationLiver TransplantationRenal TransplantationTransplantation, KidneyTransplantation, Renal

Phase 2

Study of FK778 in Renal Transplant Recipients With Untreated BK Nephropathy

TerminatedNCT00104338

Astellas Pharma IncBK Polyomavirus, Kidney Diseases

Start: 2005-01-31End: 2006-08-31Target: 45Updated: 2012-06-07

A Study to Evaluate FK778 in Kidney Transplant Patients

CompletedNCT00189735

Astellas Pharma IncGrafting, Kidney, Kidney Transplantation, Renal Transplantation +2

Start: 2003-09-30End: 2005-10-31Updated: 2008-04-17

A Study to Evaluate the Safety and Efficacy of Prograf/FK778 and Prograf/MMF in de Novo Kidney Transplant Recipients

TerminatedNCT00282230

Astellas Pharma IncKidney Transplantation

Start: 2003-11-30End: 2005-10-31Target: 150Updated: 2012-06-07

A Study to Evaluate the Safety and Effectiveness of FK778 in Liver Transplant Patients

CompletedNCT00451932

Astellas Pharma IncLiver Transplantation

Start: 2002-10-31End: 2005-09-30Updated: 2008-04-17